Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar, Ethiopia.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
14 May 2019
Historique:
received: 17 01 2019
accepted: 01 05 2019
entrez: 16 5 2019
pubmed: 16 5 2019
medline: 10 7 2019
Statut: epublish

Résumé

Human immunodeficiency virus (HIV) infected children represent a very vulnerable population for anti-retroviral therapy (ART) drug resistance. As a global target, 90% of patients receiving ART should have HIV-RNA viral suppression. A threshold of > 1000 RNA copies/ml is used to define non-suppressed viral load. If it is confirmed in the laboratory, adherence should be addressed and should be followed by the switch to second-line ART. Therefore, the aim of this study was to assess the rate of viral load suppression among children tested at the Amhara Public Health Institute (APHI), Bahir Dar. Institutional based cross-sectional study design was conducted from July 01, 2017 to June 30, 2018, in children under the age of 15 years. Socio-demographic, clinical and HIV1RNA viral load data were collected from the excel database. The data were analyzed in SPSS 20.0 statistical software. A total of 1567 children, age ranged from one to 14 years, were tested for HIV viral load. Of which, about 54% were males. Children were treated using nevirapine-based (76.7%), efavirenz-based (21.8%) and protease inhibitor-based (1.5%) anti-retroviral drugs. Non-suppressed HIV viral load was found in 28.3% of the participants. High viral load (> 1000 cp/ml) were found in 24% of the children below the age of five years. Children on nevirapine-based treatment had about two times more non-suppressed viral load (Adjusted odds ratio [AOR]: 1.90; 95%CI: 1.41-2.56; P < 0.001) compared to those who had efavirenz-based treatment. However, adherence (P: 0.204) was not associated with non-suppressed viral load. There was a high rate of non-suppressed HIV viral load among children tested at APHI. Specifically, the odds of having a non-suppressed viral load was higher in NVP based treatment users. Hence, comprehensive management and follow up of children on ART, and testing for resistance as well as viral load could help to reduce the problem in advance.

Sections du résumé

BACKGROUND BACKGROUND
Human immunodeficiency virus (HIV) infected children represent a very vulnerable population for anti-retroviral therapy (ART) drug resistance. As a global target, 90% of patients receiving ART should have HIV-RNA viral suppression. A threshold of > 1000 RNA copies/ml is used to define non-suppressed viral load. If it is confirmed in the laboratory, adherence should be addressed and should be followed by the switch to second-line ART. Therefore, the aim of this study was to assess the rate of viral load suppression among children tested at the Amhara Public Health Institute (APHI), Bahir Dar.
METHODS METHODS
Institutional based cross-sectional study design was conducted from July 01, 2017 to June 30, 2018, in children under the age of 15 years. Socio-demographic, clinical and HIV1RNA viral load data were collected from the excel database. The data were analyzed in SPSS 20.0 statistical software.
RESULTS RESULTS
A total of 1567 children, age ranged from one to 14 years, were tested for HIV viral load. Of which, about 54% were males. Children were treated using nevirapine-based (76.7%), efavirenz-based (21.8%) and protease inhibitor-based (1.5%) anti-retroviral drugs. Non-suppressed HIV viral load was found in 28.3% of the participants. High viral load (> 1000 cp/ml) were found in 24% of the children below the age of five years. Children on nevirapine-based treatment had about two times more non-suppressed viral load (Adjusted odds ratio [AOR]: 1.90; 95%CI: 1.41-2.56; P < 0.001) compared to those who had efavirenz-based treatment. However, adherence (P: 0.204) was not associated with non-suppressed viral load.
CONCLUSIONS CONCLUSIONS
There was a high rate of non-suppressed HIV viral load among children tested at APHI. Specifically, the odds of having a non-suppressed viral load was higher in NVP based treatment users. Hence, comprehensive management and follow up of children on ART, and testing for resistance as well as viral load could help to reduce the problem in advance.

Identifiants

pubmed: 31088496
doi: 10.1186/s12879-019-4058-4
pii: 10.1186/s12879-019-4058-4
pmc: PMC6518745
doi:

Substances chimiques

Alkynes 0
Anti-Retroviral Agents 0
Benzoxazines 0
Cyclopropanes 0
Nevirapine 99DK7FVK1H
efavirenz JE6H2O27P8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

419

Références

J Infect Dis. 2008 Oct 1;198(7):1075-82
pubmed: 18684096
PLoS One. 2015 Jul 10;10(7):e0131994
pubmed: 26161559
J Virus Erad. 2016 Apr 01;2(2):94-101
pubmed: 27482442
AIDS. 2017 Jan 2;31(1):61-70
pubmed: 27677163
PLoS One. 2017 Jan 31;12(1):e0170893
pubmed: 28141867
BMC Infect Dis. 2017 May 3;17(1):326
pubmed: 28468608
J Int AIDS Soc. 2017 Nov;20 Suppl 7:
pubmed: 29171190
Children (Basel). 2018 Jan 01;5(1):null
pubmed: 29301267
PLoS One. 2018 Jan 11;13(1):e0190659
pubmed: 29324811
BMC Public Health. 2018 Aug 22;18(1):1048
pubmed: 30134880
J Antimicrob Chemother. 2018 Dec 1;73(12):3471-3475
pubmed: 30169653

Auteurs

Melashu Balew Shiferaw (MB)

Amhara Public Health Institute, Bahir Dar, Ethiopia. bmelashu@gmail.com.

Demeke Endalamaw (D)

Amhara Public Health Institute, Bahir Dar, Ethiopia.

Mulat Hussien (M)

Amhara Public Health Institute, Bahir Dar, Ethiopia.

Manamnot Agegne (M)

Amhara Public Health Institute, Bahir Dar, Ethiopia.

Desalegn Amare (D)

College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.

Fikirte Estifanos (F)

Amhara Public Health Institute, Bahir Dar, Ethiopia.

Dinbere Temesgen (D)

Amhara Public Health Institute, Bahir Dar, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH